Delivery Order SPE2DX22D0010-SPE2D826FAT08
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a ceiling value of $1,055.37 and an ultimate completion date of October 1, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg, with a ceiling value of $3,780.69. The contract is a firm fixed price delivery order with an ultimate completion date of October 7, 2025, awarded on October 6, 2025. No set-aside designation was applied to this award, indicating it was competitively procured. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg with a ceiling value of $4,271.13. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. No set-aside designation was applied to this competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,866.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25mg. The contract was executed on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This was a competitive award with no set-aside designation. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,408.02 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25 mg, with a completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare systems....
- This delivery order awards $8,050.33 to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg to support federal medical procurement needs. The contract is a firm fixed price delivery order with an ultimate completion date of September 25, 2025, issued by the Defense Logistics Agency's Medical Supply Chain on September 24, 2025. The award represents a non-set-aside, competitively awarded transaction, reflecting the contractor's capability to meet...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,332.85 by the Medical Supply Chain, a defense-focused federal agency, on October 24, 2025, with an ultimate completion date of October 27, 2025. The contract covers the supply of Amphetamine Mix (Adderall) Extended Release Capsules 20mg, a controlled pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. The award is a firm fixed price delivery order with no set-aside designation,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Amphetamine Mix extended-release capsules at 37.5 mg dosage strength. This competitive delivery order, valued at $1,094.39, represents a firm fixed-price procurement with an ultimate completion date of August 14, 2025. The contract is classified as a child award, indicating it derives from a larger indefinite delivery contract vehicle. Performance of...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4559455087 amphetamine mixed extended-release capsules, 20mg, with a ceiling value of $1,030.88 and a completion date of December 27, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA, which serves as a primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of Amphetamine Mix (AD) Extended Release Capsules, 20mg, with a potential value of $1,271.37 and a completion date of January 11, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAT08Delivery Order
This delivery order, valued at $4,934.99, awards Amerisourcebergen Drug Corp the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg to support federal medical needs. The contract was awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. Funding originates from the Defense Medical Supply Chain, a defense-aligned agency responsible for pharmaceutical and medical supply procurement for military and veteran healthcare systems. This delivery order operates as a child contract under Amerisourcebergen Drug Corp's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vendor agreement enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen Drug Corp's extensive federal contract portfolio demonstrates its role as a critical pharmaceutical distributor for the Department of Defense, with delivery orders consistently utilizing competitive, firm fixed price mechanisms across diverse therapeutic categories and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 10/30/25 |